“We believe that we are at the beginning of an evolution in the chemical industry where man has the ability to replace some chemicals that have been produced via the petro route with the same chemicals now using sugar as their source of carbon instead of fossil fuels”. Mike Hartmann, executive vice president of BioAmber, talks to Il Bioeconomista
BioAmber is a sustainable chemicals company, whose proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into building block chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products. The company, which is one of the main world bioeconomy’s players, has been listed on the New York Stock Exchange since May 2013, under the symbol BIOA. And is also listed on the NYSE Euronext Paris exchange, under the same symbol. BioAmber is a Delaware corporation with a head office in Montreal, Quebec, Canada, a research facility in Plymouth (Minneapolis), Minnesota, and a commercial plant operating in Sarnia, Ontario, Canada. Its investors include Sofinnova Partners (France), Naxos Capital Partners (Luxemburg), Mitsui & Co. (Japan), Lanxess (Germany) and the Cliffton Group (Canada).
Interview by Mario Bonaccorso
Metabolix, an U.S. advanced biomaterials company focused on sustainable solutions for the plastics industry, announced that it has entered into a Memorandum of Understanding with CJ CheilJedang Corporation (“CJ”) for a strategic commercial manufacturing arrangement for specialty PHAs, including the Company’s newly launched amorphous PHA (“a-PHA”).
